![](/img/cover-not-exists.png)
Survival Benefit of Intravenous Busulfan (120 mg/M2) and Fludarabine Myeloablative Regimen for Treatment of Myeloid Malignancies
P, NiparuckVolume:
6
Year:
2016
Language:
english
Journal:
Journal of Stem Cell Research & Therapy
DOI:
10.4172/2157-7633.1000338
File:
PDF, 354 KB
english, 2016